A comprehensive biomarker diagnostic panel for assessing the progression risk of diabetic kidney disease and predicting end-stage kidney disease development. The test utilizes novel biomarker technologies to stratify patient risk and guide personalized treatment decisions.
Manufactured by
Zhubei City, Hsinchu, Taiwan
Bio Preventive Medicine (BPM) is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product. Started from an ITRI (a Taiwanese national lab and global top 100 innovator) spin-off in 2014 to launch the first product " DNlite ", BPM is now growing into a leading company in innovative renal diagnostic solution, with a GMP (Taiwan FDA) /QMS accredited plant & ISO 17025 accredited Lab Facilities at Hsinchu, Taiwan. The company has demonstrated excellence with domain expertise in translational research and IVD development, brought up a new revolutionary page of precision medicine. DNlite, an ELISA based non-invasive urinary test for monitoring the progression of Diabetic Nephropathy, is an effective tool for screening, detecting and monitoring kidney complications in diabetes. Unlike the current standard test (known as eGFR and UACR) can only detect the disease once it's already present, DNlite predicts kidney function loss years in advance. It can be also applied in CKD, AKD, and Kidney Transplant. In addition to diabetic nephropathy, the proprietary technology of BPM also include biomarker-based diagnostic technology for other chronic diseases and oncology. At Bio Preventive Medicine Corp. , we hold significant intellectual property rights for our clinically validated biomarker product and are very interested in pursuing business partnerships via licensing, co-development, clinical research projects, or product distribution.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
CareforU Co., Ltd.
South Korea · 1 relevant product
Chongqing BIOSTEC Biotechnology Co., Ltd
China · 4 relevant products
Wuxi BioHermes Bio & Medical Technology Co., Ltd.
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 4 relevant products
FIRSTLAB
Brazil · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 2 relevant products
TMD LAB CO., LTD.
South Korea · 1 relevant product
Hangzhou Lysun Biotechnology Co.,Ltd
China · 2 relevant products
Ningbo Masschip Intelligent Technology Co., Ltd.
China · 1 relevant product
Bioantibody Biotechnology Co., Ltd.
China · 3 relevant products
65 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 108 closest product alternatives
CareforU Co., Ltd. · South Korea
Comprehensive in vitro diagnostic testing panel for assessment of kidney function and detection of renal disease. Includes measurement of relevant biomarkers and clinical parameters.
Chongqing BIOSTEC Biotechnology Co., Ltd · China
Specialized diagnostic panel for chronic kidney disease detection and monitoring. Focuses on early identification of kidney dysfunction through specific protein biomarker analysis.
Wuxi BioHermes Bio & Medical Technology Co., Ltd. · China
Comprehensive diabetes screening using multiple biomarkers including fasting blood glucose, 2-hour oral glucose tolerance test results, and glycated hemoglobin levels. Enables early detection and stratification of diabetes risk in high-risk populations.
Anbio Biotechnology Limited · Germany
Metabolic testing suite measuring glucose, HbA1c, and related biomarkers for diabetes assessment. Enables risk stratification and disease monitoring.
FIRSTLAB · Brazil
Laboratory test panel for evaluating kidney function and assessing renal disease. Includes multiple analytes for comprehensive renal assessment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Comprehensive diagnostic panel for personalized treatment selection in cardiovascular and oncology diseases. Analyzes multiple genetic and molecular markers to guide clinical decision-making.
TMD LAB CO., LTD. · South Korea
Tests measuring creatinine, blood urea nitrogen, and glomerular filtration rate. Assesses renal function and monitors kidney disease progression.
Hangzhou Lysun Biotechnology Co.,Ltd · China
A comprehensive test measuring kidney function markers including creatinine, urea, and uric acid. Used to assess renal status and kidney disease progression.
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Measurement of kidney function markers including creatinine and urea. Essential for assessing renal disease and drug dosing.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative test measuring renal function markers including creatinine and electrolytes. Assesses kidney functionality and detects renal impairment.
Polaris Diagnostics Europe UG · Germany
Integrated diagnostic panel measuring vitamin D, inflammatory markers, and wound healing indicators specific to dental implant procedures. Optimizes perioperative risk stratification.
HVD Vertriebs GmbH · Austria
Specialized diagnostic panel for assessment of anaphylactogenic molecules and anaphylaxis risk factors. Supports patient stratification and clinical management of severe allergic reactions.
96 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products